4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,095.46p
   
  • Change Today:
    -14.55p
  • 52 Week High: 1,820.00
  • 52 Week Low: 1,095.46
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 0
  • Market Cap: £169.76m

Regulatory News

4basebio Plc - Final Results and Notice of AGM 27-May-2025 07:00 PR Newswire
4basebio Plc - Director Dealing 04-Apr-2025 12:00 PR Newswire
4basebio Plc - 4basebio Receives GMP Licence for... 02-Apr-2025 07:00 PR Newswire
4basebio Plc - Holding(s) in Company 25-Mar-2025 10:15 PR Newswire
4basebio Plc - RBC Capital Markets initiates res... 14-Mar-2025 07:00 PR Newswire
4basebio Plc - Employee Long Term Incentive Plan... 07-Mar-2025 07:00 PR Newswire
4basebio Plc - Director's Dealing 03-Mar-2025 16:37 PR Newswire
4basebio Plc - Appointment of Chief Commercial O... 08-Jan-2025 07:00 PR Newswire
4basebio Plc - Directorate Change 17-Dec-2024 07:00 PR Newswire
4basebio Plc - Director's Dealing 29-Nov-2024 12:30 PR Newswire
4basebio Plc - Director's Dealing 19-Nov-2024 14:15 PR Newswire
4basebio Plc - Holding(s) in Company 15-Nov-2024 17:31 PR Newswire
4basebio Plc - Holding(s) in Company 15-Nov-2024 17:30 PR Newswire
4basebio Plc - Holding(s) in Company 15-Nov-2024 17:30 PR Newswire
4basebio Plc - Holding(s) in Company 15-Nov-2024 17:30 PR Newswire
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,095.46p
Change Today -14.55p
% Change -1.31 %
52 Week High 1,820.00
52 Week Low 1,095.46
Volume 0
Shares Issued 15.50m
Market Cap £169.76m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.31% below the market average67.31% below the market average67.31% below the market average67.31% below the market average67.31% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
Price Trend
8.99% below the market average8.99% below the market average8.99% below the market average8.99% below the market average8.99% below the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Income Not Available
Growth
57.05% above the market average57.05% above the market average57.05% above the market average57.05% above the market average57.05% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

4basebio Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page